The University of Southampton
University of Southampton Institutional Repository

Early oxidative stress response in patients with severe aortic stenosis undergoing transcatheter and surgical aortic valve replacement - a transatlantic study

Early oxidative stress response in patients with severe aortic stenosis undergoing transcatheter and surgical aortic valve replacement - a transatlantic study
Early oxidative stress response in patients with severe aortic stenosis undergoing transcatheter and surgical aortic valve replacement - a transatlantic study
Myocardial ischemia/reperfusion related oxidative stress as a result of cardiopulmonary bypass is thought to contribute to the adverse clinical outcomes following surgical aortic valve replacement (SAVR). Although the acute response following this procedure has been well characterized, much less is known about the nature and extent of oxidative stress induced by the transcatheter aortic valve replacement (TAVR) procedure. We therefore sought to examine and directly compare the oxidative stress response in patients undergoing TAVR and SAVR. A total of 60 patients were prospectively enrolled in this exploratory study, 38 patients undergoing TAVR and 22 patients SAVR. Reduced and oxidized glutathione (GSH, GSSG) in red blood cells as well as the ferric reducing ability of plasma (FRAP) and plasma concentrations of 8-isoprostanes were measured at baseline (S1), during early reperfusion (S2), and 6-8 hours (S3) following aortic valve replacement (AVR). TAVR and SAVR were successful in all patients. Patients undergoing TAVR were older (79.3±9.5 vs. 74.2±4.1 years; p<0.01) and had a higher mean STS risk score (6.6±4.8 vs. 3.2±3.0; p<0.001) than patients undergoing SAVR. At baseline, FRAP and 8- isoprostane plasma concentrations were similar between the two groups, but erythrocytic GSH concentrations were significantly lower in the TAVR group. After AVR, FRAP was markedly higher in the TAVR group, whereas 8-isoprostane concentrations were significantly elevated in the SAVR group. In conclusion, TAVR appears not to cause acute oxidative stress and may even improve the antioxidant capacity in the extracellular compartment.
1942-0900
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Gormaz, Juan Guillermo
1710e10e-b879-4894-9da3-863d9f913641
Erazo, Marcia
00d2932f-e8c8-4da7-8268-ba0e64f36f7a
Howard, Michael
c68e2702-430b-4e17-b54b-79d9f6349301
Baeza, Cristina
1dc860cb-f542-4c0e-b251-5d9914c0f2a9
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Curzen, Nicholas
70f3ea49-51b1-418f-8e56-8210aef1abf4
Olechowski, Bartosz
b025b40b-f9fa-4b8e-8f57-310d47e57700
Fernandez, Bernadette
9890aabc-1fe6-4530-a51e-31182e537131
Minnion, Magdalena
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Mikus-Lelinska, Monika
6ca48669-ff8f-4ae8-9d10-98c74327b4ec
Meiss, Mia S.
dd08a521-c48e-4a91-98ca-13c0548af7c5
Lau, Laurie
2af8045d-6162-4939-aba7-28dd2f60f6a8
Valls, Nicolas
b3f7a08e-ff50-461c-949a-5b531591d10d
Gajardo, Abraham
42df2c8c-6457-4971-a488-6f915a31b855
Rivotta, Amy
6a00a6a3-aa7a-4334-869b-9f8930db06c4
Carrasco, Rodrigo
474c5013-15b2-4257-97fe-9d30ee87ce9e
Cavada, Gabriel
96b0a6a5-dff9-4fc9-af5c-b845cd24ea88
Vergara, Maria Jesus
cb410f2c-a726-432d-915b-8a804cda39d0
Maluenda, Gabriel
99efede8-02b1-4d1c-aefa-d98bef1a57c4
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Gormaz, Juan Guillermo
1710e10e-b879-4894-9da3-863d9f913641
Erazo, Marcia
00d2932f-e8c8-4da7-8268-ba0e64f36f7a
Howard, Michael
c68e2702-430b-4e17-b54b-79d9f6349301
Baeza, Cristina
1dc860cb-f542-4c0e-b251-5d9914c0f2a9
Feelisch, Martin
8c1b9965-8614-4e85-b2c6-458a2e17eafd
Curzen, Nicholas
70f3ea49-51b1-418f-8e56-8210aef1abf4
Olechowski, Bartosz
b025b40b-f9fa-4b8e-8f57-310d47e57700
Fernandez, Bernadette
9890aabc-1fe6-4530-a51e-31182e537131
Minnion, Magdalena
ab23b32b-9f8e-4876-aaf5-99cb6a725a2f
Mikus-Lelinska, Monika
6ca48669-ff8f-4ae8-9d10-98c74327b4ec
Meiss, Mia S.
dd08a521-c48e-4a91-98ca-13c0548af7c5
Lau, Laurie
2af8045d-6162-4939-aba7-28dd2f60f6a8
Valls, Nicolas
b3f7a08e-ff50-461c-949a-5b531591d10d
Gajardo, Abraham
42df2c8c-6457-4971-a488-6f915a31b855
Rivotta, Amy
6a00a6a3-aa7a-4334-869b-9f8930db06c4
Carrasco, Rodrigo
474c5013-15b2-4257-97fe-9d30ee87ce9e
Cavada, Gabriel
96b0a6a5-dff9-4fc9-af5c-b845cd24ea88
Vergara, Maria Jesus
cb410f2c-a726-432d-915b-8a804cda39d0
Maluenda, Gabriel
99efede8-02b1-4d1c-aefa-d98bef1a57c4

Mahmoudi, Michael, Gormaz, Juan Guillermo, Erazo, Marcia, Howard, Michael, Baeza, Cristina, Feelisch, Martin, Curzen, Nicholas, Olechowski, Bartosz, Fernandez, Bernadette, Minnion, Magdalena, Mikus-Lelinska, Monika, Meiss, Mia S., Lau, Laurie, Valls, Nicolas, Gajardo, Abraham, Rivotta, Amy, Carrasco, Rodrigo, Cavada, Gabriel, Vergara, Maria Jesus and Maluenda, Gabriel (2019) Early oxidative stress response in patients with severe aortic stenosis undergoing transcatheter and surgical aortic valve replacement - a transatlantic study. Oxidative Medicine and Cellular Longevity. (In Press)

Record type: Article

Abstract

Myocardial ischemia/reperfusion related oxidative stress as a result of cardiopulmonary bypass is thought to contribute to the adverse clinical outcomes following surgical aortic valve replacement (SAVR). Although the acute response following this procedure has been well characterized, much less is known about the nature and extent of oxidative stress induced by the transcatheter aortic valve replacement (TAVR) procedure. We therefore sought to examine and directly compare the oxidative stress response in patients undergoing TAVR and SAVR. A total of 60 patients were prospectively enrolled in this exploratory study, 38 patients undergoing TAVR and 22 patients SAVR. Reduced and oxidized glutathione (GSH, GSSG) in red blood cells as well as the ferric reducing ability of plasma (FRAP) and plasma concentrations of 8-isoprostanes were measured at baseline (S1), during early reperfusion (S2), and 6-8 hours (S3) following aortic valve replacement (AVR). TAVR and SAVR were successful in all patients. Patients undergoing TAVR were older (79.3±9.5 vs. 74.2±4.1 years; p<0.01) and had a higher mean STS risk score (6.6±4.8 vs. 3.2±3.0; p<0.001) than patients undergoing SAVR. At baseline, FRAP and 8- isoprostane plasma concentrations were similar between the two groups, but erythrocytic GSH concentrations were significantly lower in the TAVR group. After AVR, FRAP was markedly higher in the TAVR group, whereas 8-isoprostane concentrations were significantly elevated in the SAVR group. In conclusion, TAVR appears not to cause acute oxidative stress and may even improve the antioxidant capacity in the extracellular compartment.

Text
OMCL6217837_Rev2 - Accepted Manuscript
Download (299kB)

More information

Accepted/In Press date: 17 September 2019

Identifiers

Local EPrints ID: 434491
URI: https://eprints.soton.ac.uk/id/eprint/434491
ISSN: 1942-0900
PURE UUID: d2574132-2794-4cb0-9683-95a729aa7297
ORCID for Michael Mahmoudi: ORCID iD orcid.org/0000-0003-1293-8461
ORCID for Martin Feelisch: ORCID iD orcid.org/0000-0003-2320-1158
ORCID for Bernadette Fernandez: ORCID iD orcid.org/0000-0001-6337-0381

Catalogue record

Date deposited: 25 Sep 2019 16:30
Last modified: 26 Sep 2019 00:33

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×